R J Rodenburg
Overview
Explore the profile of R J Rodenburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodenburg R, Eskens F
Int J Nephrol Renovasc Dis
. 2019 Jun;
12:137-141.
PMID: 31190952
Tivozanib is an oral selective vascular endothelial growth factors receptor (VEGFR) tyrosine kinase inhibitor that is recently approved by the European Medicines Agency for the treatment of previously untreated patients...
2.
Janssen L, Frambach S, Allard N, Hopman M, Schirris T, Voermans N, et al.
Leukemia
. 2019 Mar;
33(8):2116-2120.
PMID: 30872782
No abstract available.
3.
Godiker J, Gruneberg M, DuChesne I, Reunert J, Rust S, Westermann C, et al.
J Hum Genet
. 2018 Apr;
63(6):707-716.
PMID: 29618761
Seven subunits of the mitochondrial contact site and cristae junction (CJ) organizing system (MICOS) in humans have been recently described in function and structure. QIL1 (also named MIC13) is a...
4.
Rodenburg R, Hanssens P, Ho V, Beerepoot L
J Neurooncol
. 2018 Feb;
138(2):391-399.
PMID: 29470692
Melanoma brain metastases (MBM) are common in patients with stage IV disease. For Gamma Knife radiosurgery (GKRS) on MBM, risk scores such as RPA and melanoma-GPA aid to identify prognostic...
5.
Balasubramaniam S, Lewis B, Mock D, Said H, Tarailo-Graovac M, Mattman A, et al.
JIMD Rep
. 2017 Oct;
33:111.
PMID: 29076057
No abstract available.
6.
Panneman D, Smeitink J, Rodenburg R
Clin Genet
. 2017 Jul;
93(5):943-951.
PMID: 28686290
Mitochondrial disorders (MDs) are caused by defects in 1 or multiple complexes of the oxidative phosphorylation (OXPHOS) machinery. MDs are associated with a broad range of clinical signs and symptoms,...
7.
Rodenburg R, Wijnands M, Rensma P
Ned Tijdschr Geneeskd
. 2017 Jan;
161:D575.
PMID: 28120731
Methotrexate is a frequently prescribed drug and is considered to be safe at a low dosage. However, serious complications may occur during treatment. In this article we describe a 78-year-old...
8.
Al Mutairi F, Shamseldin H, Alfadhel M, Rodenburg R, Alkuraya F
Clin Genet
. 2016 Dec;
91(4):629-633.
PMID: 27905109
Short-chain enoyl-CoA hydratase (SCEH) is a mitochondrial enzyme involved in the oxidation of fatty acids and the catabolic pathway of valine and, to a lesser extent, isoleucine. Deficiency of this...
9.
Balasubramaniam S, Lewis B, Mock D, Said H, Tarailo-Graovac M, Mattman A, et al.
JIMD Rep
. 2016 Jul;
33:99-107.
PMID: 27450367
Leigh syndrome (LS), or subacute necrotizing encephalomyelopathy, is a genetically heterogeneous, relentlessly progressive, devastating neurodegenerative disorder that usually presents in infancy or early childhood. A diagnosis of Leigh-like syndrome may...
10.
Smits P, Rodenburg R, Smeitink J, van den Heuvel L
J Inherit Metab Dis
. 2013 Oct;
33 Suppl 3:S13-9.
PMID: 24137763
The oxidative phosphorylation (OXPHOS) system, comprising five enzyme complexes, is located in the inner membrane of mitochondria and is the final biochemical pathway in oxidative ATP production. Defects in this...